These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12042561)

  • 81. Pharmacokinetics and bactericidal activity of cefuroxime axetil.
    Ginsburg CM; McCracken GH; Petruska M; Olson K
    Antimicrob Agents Chemother; 1985 Oct; 28(4):504-7. PubMed ID: 3878129
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Sinusitis Study Group.
    Gehanno P; Berche P
    J Antimicrob Chemother; 1996 May; 37 Suppl A():105-14. PubMed ID: 8737130
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Multicenter comparative trial of ciprofloxacin versus cefuroxime axetil in the treatment of acute rhinosinusitis in a primary care setting. Rhinosinusitis Investigation Group.
    Weis M; Hendrick K; Tillotson G; Gravelle K
    Clin Ther; 1998; 20(5):921-32. PubMed ID: 9829444
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Single-dose cefuroxime axetil versus multiple-dose cefaclor in the treatment of acute urinary tract infections.
    Iravani A; Richard GA
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1212-6. PubMed ID: 2802549
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Treatment and prevention of Lyme disease.
    Hansmann Y
    Curr Probl Dermatol; 2009; 37():111-129. PubMed ID: 19367098
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Pharmacoeconomic analysis of patients with acute exacerbation of chronic bronchitis treated with telithromycin or cefuroxime-axetil].
    Rubio-Terrés C; Cots JM; Domínguez-Gil A; Herreras A; Sánchez Gascón F; Chang J; Trilla A
    Rev Clin Esp; 2004 Nov; 204(11):567-73. PubMed ID: 15511402
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Sequential therapy with cefuroxime and cefuroxime-axetil for community-acquired lower respiratory tract infection in the oldest old.
    Flamaing J; Knockaert D; Meijers B; Verhaegen J; Peetermans WE
    Aging Clin Exp Res; 2008 Feb; 20(1):81-6. PubMed ID: 18283233
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Solitary erythema migrans in children: comparison of treatment with clarithromycin and amoxicillin.
    Nizič T; Velikanje E; Ružić-Sabljić E; Arnež M
    Wien Klin Wochenschr; 2012 Jul; 124(13-14):427-33. PubMed ID: 22760494
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Pharmacokinetics of cefuroxime axetil suspension in infants and children.
    Powell DA; James NC; Ossi MJ; Nahata MC; Donn KH
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2042-5. PubMed ID: 1759825
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Variation in acceptance of common oral antibiotic suspensions.
    Dagan R; Shvartzman P; Liss Z
    Pediatr Infect Dis J; 1994 Aug; 13(8):686-90. PubMed ID: 7970967
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Bioavailability of cefuroxime axetil formulations.
    Donn KH; James NC; Powell JR
    J Pharm Sci; 1994 Jun; 83(6):842-4. PubMed ID: 9120818
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Effect of dose and food on the bioavailability of cefuroxime axetil.
    Finn A; Straughn A; Meyer M; Chubb J
    Biopharm Drug Dispos; 1987; 8(6):519-26. PubMed ID: 3427209
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Doxycycline versus tetracycline therapy for Lyme disease associated with erythema migrans.
    Nowakowski J; Nadelman RB; Forseter G; McKenna D; Wormser GP
    J Am Acad Dermatol; 1995 Feb; 32(2 Pt 1):223-7. PubMed ID: 7829706
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Narrow- versus broad-spectrum parenteral anatimicrobials against common infections of childhood: a prospective and randomised comparison between penicillin and cefuroxime.
    Vuori-Holopainen E; Peltola H; Kallio MJ;
    Eur J Pediatr; 2000 Dec; 159(12):878-84. PubMed ID: 11131342
    [TBL] [Abstract][Full Text] [Related]  

  • 95. An evaluation of the safety of cefuroxime axetil during six months oral administration to beagle dogs.
    Spurling NW; Harcourt RA; Hyde JJ
    J Toxicol Sci; 1986 Nov; 11(4):237-77. PubMed ID: 3820342
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Intestinal transport of cefuroxime axetil in rats: absorption and hydrolysis processes.
    Ruiz-Balaguer N; Nacher A; Casabo VG; Merino Sanjuan M
    Int J Pharm; 2002 Mar; 234(1-2):101-11. PubMed ID: 11839441
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Survival following group A streptococcal septicaemia in a centenarian.
    Galloway A; Glesson HK
    J Infect; 1999 May; 38(3):193-4. PubMed ID: 10424802
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Nonlinear intestinal absorption kinetics of cefuroxime axetil in rats.
    Ruiz-Balaguer N; Nacher A; Casabo VG; Merino M
    Antimicrob Agents Chemother; 1997 Feb; 41(2):445-8. PubMed ID: 9021205
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A large scale, general practice based investigation into the clinical efficacy and tolerability of cefuroxime axetil in women with uncomplicated urinary tract infection.
    Bulpitt D; Potter CE; Jaderberg M
    Curr Med Res Opin; 1991; 12(5):318-24. PubMed ID: 2004544
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Treatment of Lyme arthritis.
    Steere AC; Levin RE; Molloy PJ; Kalish RA; Abraham JH; Liu NY; Schmid CH
    Arthritis Rheum; 1994 Jun; 37(6):878-88. PubMed ID: 8003060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.